Skip to content
Preprint

Target-Weighted Neyman Allocation: Experimental Design for Heterogeneous Treatment Effects under Population Shift

Aug 2026 · 0 citations · 26 references
Computer Science Mathematics

Abstract

Randomized experiments are often run in one population to guide decisions in another. Allocating by experimental proportions wastes budget on groups that rarely appear in deployment, whereas allocating by deployment proportions under-samples groups that are hard to measure precisely. We propose \textbf{TWNA} (Target-Weighted Neyman Allocation), a two-stage stratified design that uses pilot estimates of group--arm outcome variances to allocate final-stage sample sizes and treatment probabilities for target-weighted group average treatment effect (GATE) precision. The oracle rule has a closed form and balances deployment importance with statistical difficulty; the plug-in rule recovers it as pilot variance estimates stabilize. We also extend TWNA to handle uncertainty about deployment composition, remaining robust whether the target mix is roughly known or entirely unknown. Finally, we distinguish this weight robustness from a pilot-robust variant for skewed, rare-event, or contaminated outcomes. Simulations and real-covariate benchmarks show the largest gains when groups are both deployment-important and difficult to measure.

View source

Similar papers

Preprint Sep 2026

Target-Aware Sequential Inference: Pooled versus Stratified Anytime-Valid Designs

Sequential studies with heterogeneous strata may define the estimand under a target mixture that differs from the sampling distribution. We organize the design problem by guarantee class: one pooled confidence sequence for a single prespecified target, shared pooled inference for a prespecified target set, and stratum-...

Subir Hait · 0 citations
Review Open access May 2025

What is estimated in cluster randomized crossover trials with informative sizes? A survey of estimands and common estimators

The cluster randomized crossover (CRXO) trial, among other multi-period cluster randomized trial designs, can target average treatment effect (ATE) estimands that equally weigh the contributions of individuals (iATE), clusters (cATE), cluster-periods (cpATE), or periods (pATE). With these weighted ATE estimands, we def...

Kenneth M. Lee, A. Forbes, Jessica Kasza et al. · 4 citations
Case report Open access Aug 2026

Optimal Experimental Design and Estimation when Potential Outcomes are Bounded

I study the optimal design and analysis of randomized experiments for estimating finite-population average treatment effects when potential outcomes are known to be bounded, as with binary outcomes. Among all assignment mechanisms and a broad class of affine estimators, worst-case mean-squared error (MSE) is minimized...

Peter Hull · 0 citations
Preprint Sep 2026

EARL: Exposure- and Allocation-Reweighted Linear Estimator for Bipartite Experiments with Partial Assignment

Bipartite A/B tests are experiments in which treatment is randomised over one set of units, while outcomes are measured on another. For example, an online marketplace may test a new pricing algorithm on a random subset of items, while the outcome of interest, say, purchase satisfaction, is measured on customers, each o...

A. Kurennoy · 0 citations
Open access Mar 2025

Integrating Meta-Analysis Into a Specific Study (InMASS) for Estimating the Target-Population Average Treatment Effect.

Randomized controlled trials remain the benchmark for estimating treatment effects, yet practical constraints often restrict sample sizes in a prespecified target population. In such settings, evidence from completed trials is frequently available only in aggregate form, which precludes direct individual-level integrat...

Keisuke Hanada, M. Kojima · 1 citation
Preprint Aug 2026

Transporting Trial Evidence Under Posterior Drift and Possible Hidden Confounding

Randomized trials provide internally valid treatment-effect evidence, but trial participants may not represent the target population. In contrast, observational studies are often closer to the target population, but their treatment assignment may be affected by possible hidden confounding. We develop a robust posterior...

X. Mao, Bosen Cui, Yuhong Yang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.